Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease, on Dialysis.
Status:
Completed
Trial end date:
2018-09-26
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of roxadustat compared to
epoetin alfa for the treatment of anemia in chronic kidney disease patients on dialysis.